18.84

0.83% 0.13

After Hours: 19.00 0.16 +0.85%

Baxter International Inc (BAX)

Overview News Price History Option Chain Financials Why BAX Down? Discussions Forecast Stock Split Dividend History

Baxter International Inc stock is traded at $18.84, with a volume of 6.73M. It is up +0.83% in the last 24 hours and up +16.81% over the past month. Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Previous Close:

$18.71

Open:

$18.47

24h Volume:

6.73M

Relative Volume:

0.71

Market Cap:

$9.73B

Revenue:

$11.24B

Net Income/Loss:

$-900.00M

P/E Ratio:

-11.22

EPS:

-1.679

Net Cash Flow:

$323.00M

1W Performance:

+7.01%

1M Performance:

+16.81%

6M Performance:

-18.44%

1Y Performance:

-34.70%

1-Day Range:

$18.42

$18.97

1-Week Range:

$17.45

$19.19

52-Week Range:

$15.73

$32.68

Baxter International Inc Stock (BAX) Company Profile

Name

Baxter International Inc

Sector

Healthcare (1119)

Industry

Medical Instruments & Supplies (57)

Phone

(224) 948-2000

Address

ONE BAXTER PARKWAY, DEERFIELD, IL

Employee

37,500

Twitter

@baxter_intl

Next Earnings Date

2026-04-30

Latest SEC Filings

BAX's Discussions on Twitter

Compare BAX vs ISRG, BDX, MDLN, ALC, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BAX Baxter International Inc	18.84	9.66B	11.24B	-900.00M	323.00M	-1.679
ISRG Intuitive Surgical Inc	465.60	166.65B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	158.64	45.10B	21.92B	1.76B	2.63B	6.1223
MDLN Medline Inc	48.26	38.67B	28.43B	1.16B	1.26B	1.4457
ALC Alcon Inc	80.30	39.64B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	226.14	33.23B	5.40B	1.49B	1.78B	10.12

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-31-25	Downgrade	Argus	Buy → Hold
Aug-04-25	Downgrade	Stifel	Buy → Hold
Aug-01-25	Downgrade	Goldman	Buy → Neutral
Feb-26-25	Resumed	Goldman	Buy
Feb-24-25	Upgrade	Argus	Hold → Buy
Feb-20-25	Resumed	Barclays	Overweight
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
May-30-24	Initiated	Goldman	Neutral
May-10-24	Downgrade	TD Cowen	Buy → Hold
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-29-23	Initiated	UBS	Neutral
Jan-06-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-03-23	Downgrade	BofA Securities	Buy → Neutral
Dec-19-22	Downgrade	JP Morgan	Overweight → Neutral
Dec-15-22	Downgrade	Deutsche Bank	Buy → Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Hold
Jun-24-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-04-22	Downgrade	Goldman	Neutral → Sell
Mar-02-22	Resumed	BofA Securities	Buy
Feb-18-22	Reiterated	KeyBanc Capital Markets	Overweight
Feb-18-22	Reiterated	Morgan Stanley	Overweight
Feb-18-22	Reiterated	Raymond James	Outperform
Feb-18-22	Reiterated	Stifel	Buy
Feb-18-22	Reiterated	UBS	Neutral
Feb-18-22	Reiterated	Wells Fargo	Overweight
Feb-11-22	Initiated	Goldman	Neutral
Jan-07-22	Resumed	Citigroup	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-13-21	Upgrade	Cowen	Market Perform → Outperform
Sep-03-21	Upgrade	Barclays	Equal Weight → Overweight
May-25-21	Initiated	Barclays	Equal Weight
Jan-29-21	Downgrade	Piper Sandler	Overweight → Neutral
Jan-06-21	Downgrade	UBS	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Oct-01-20	Upgrade	Citigroup	Neutral → Buy
Sep-04-20	Downgrade	Argus	Buy → Hold
Jun-24-20	Initiated	Oppenheimer	Outperform
Mar-19-20	Upgrade	Stifel	Hold → Buy
Mar-18-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-05-20	Initiated	Citigroup	Neutral
Feb-13-20	Initiated	Goldman	Buy
Jan-02-20	Upgrade	Evercore ISI	In-line → Outperform
Dec-17-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-26-19	Initiated	KeyBanc Capital Markets	Sector Weight
Apr-08-19	Downgrade	Evercore ISI	Outperform → In-line
Jan-02-19	Upgrade	Citigroup	Neutral → Buy
Jan-02-19	Upgrade	Morgan Stanley	Underweight → Overweight
Nov-02-18	Upgrade	Argus	Hold → Buy
Oct-16-18	Initiated	Barclays	Underweight
May-17-18	Resumed	Piper Jaffray	Overweight
Feb-06-18	Reiterated	Citigroup	Neutral
Jan-03-18	Initiated	Evercore ISI	Outperform
Jan-03-18	Upgrade	Raymond James	Mkt Perform → Outperform

View All

Baxter International Inc Stock (BAX) Latest News

08:23 AM

Assessing Baxter International (BAX) Valuation After New Surgical Table And Smart Stretcher Unveiling - Sahm

Apr 19, 2026

Apr 17, 2026

Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 17, 2026

Apr 16, 2026

Is It Too Late to Buy Baxter International Inc (BAX) After 3.1% Rally? GF Value Says Undervalued - GuruFocus

Apr 16, 2026

Baxter International (BAX) Q4 earnings lag estimates - MSN

Apr 16, 2026

Is It Time To Reassess Baxter International (BAX) After A 35.9% One Year Share Price Slide - Yahoo Finance

Apr 16, 2026

Blood And Blood Components Market Is Booming So Rapidly | Baxter - openPR.com

Apr 16, 2026

BAX Stock Price, Quote & Chart | BAXTER INTERNATIONAL INC (NYSE:BAX) - ChartMill

Apr 16, 2026

Apr 15, 2026

Baxter International Inc. stock (US0673431090): Why does its hospital supply edge matter more now fo - AD HOC NEWS

Apr 15, 2026

Apr 14, 2026

Tiffany Zack joins Baxter as director of sustainability - Medical Buyer

Apr 14, 2026

Baxter International Inc stock (US0718131099): Is its medtech stability the real edge in uncertain m - AD HOC NEWS

Apr 14, 2026

Baxter Showcases Recent Innovations at AORN Global Surgical Conference and Expo 2026 - marketscreener.com

Apr 14, 2026

Baxter Welcomes Tiffany Zack as Director of Sustainability - Healthcare Digital

Apr 14, 2026

Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026 - National Today

Apr 14, 2026

Apr 13, 2026

Baxter Highlights New Surgical and Patient Support Products - National Today

Apr 13, 2026

BAX Showcases Innovative Products at Global Surgical Conference - GuruFocus

Apr 13, 2026

Will Baxter’s New IV Automation Tool Subtly Reshape Its Patient Safety Edge and Valuation Story (BAX)? - Sahm

Apr 13, 2026

Gap Down: Is Baxter International Inc a cyclical or defensive stockQuarterly Growth Report & Growth Focused Investment Plans - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Short Squeeze: Is Baxter International Inc a cyclical or defensive stock2026 Macro Moves & Low Risk Growth Stock Ideas - baoquankhu1.vn

Apr 11, 2026

Apr 09, 2026

Baxter Launches Pilot Program for Therapy Animals in Healthcare Settings - respiratory-therapy.com

Apr 09, 2026

Baxter International Provides FY 2026 Earnings Guidance - National Today

Apr 09, 2026

Baxter (NYSE: BAX) exec holds 31K shares plus 25.9K options - Stock Titan

Apr 09, 2026

Baxter (NYSE: BAX) surgery chief lists common shares and option grants - Stock Titan

Apr 09, 2026

[Form 3] BAXTER INTERNATIONAL INC Initial Statement of Beneficial Ownership - Stock Titan

Apr 09, 2026

J&J Defends Blood-Clotting Powder IP From Baxter Attack - Law360

Apr 09, 2026

Alpha Buying: Following Conviction, Not the CrowdAvantor (NYSE:AVTR), Baxter International (NYSE:BAX) - Benzinga

Apr 09, 2026

Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032 - GlobeNewswire Inc.

Apr 09, 2026

Baxter International (NYSE:BAX) Issues FY 2026 Earnings Guidance - MarketBeat

Apr 09, 2026

Apr 08, 2026

Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors - marketscreener.com

Apr 08, 2026

Baxter schedules April 30 webcast for first-quarter 2026 results - Stock Titan

Apr 08, 2026